Target Blood Pressure Values in Ambulatory Blood Pressure Monitoring

Overview

Journal High Blood Press Cardiovasc Prev

Specialty Cardiology & Vascular Diseases

Date 2022 Nov 17

PMID 36396904

Authors

Katarzyna Lewandowska

Stanislaw Wasiliew

Agata Kukfisz

Michal Hofman

Patrycja Wozniak

Artur Radziemski

Lukasz Stryczynski

Dawid Lipski

Andrzej Tykarski

Pawel Uruski

Affiliations

Soon will be listed here.

Abstract

Introduction: 2018 ESC/ESH guidelines have recommended 24-h ambulatory blood pressure monitoring to assess hypotensive therapy in many circumstances. Recommended target blood pressure in office blood pressure measurements is between 120/70 and 130/80 mmHg. Such targets for 24-h ambulatory blood pressure monitoring lacks.

Aim: We aimed to define target values of blood pressure in 24-h ambulatory blood pressure monitoring in hypertensive patients.

Methods: Office blood pressure measurements and 24-h ambulatory blood pressure monitoring data were collected from 1313 hypertensive patients and sorted following increasing systolic (SBP)/diastolic (DBP) blood pressure in office blood pressure measurements. The corresponding 24-h ambulatory blood pressure monitoring to office blood pressure measurements values were calculated.

Results: Values 130/80 mmHg in office blood pressure measurements correspond in 24-h ambulatory blood pressure monitoring: night-time SBP/DBP mean: 113.74/66.95 mmHg; daytime SBP/DBP mean: 135.02/81.78 mmHg and 24-h SBP/DBP mean: 130.24/78.73 mmHg. Values 120/70 mmHg in office blood pressure measurements correspond in 24-h ambulatory blood pressure monitoring: night-time SBP/DBP mean: 109.50/63.43 mmHg; daytime SBP/DBP mean: 131.01/78.47 mmHg and 24-h SBP/DBP mean: 126.36/75.31 mmHg.

Conclusions: The proposed blood pressure target values in 24-h ambulatory blood pressure monitoring complement the therapeutic target indicated in the ESC/ESH recommendations and improves 24-h ambulatory blood pressure monitoring usefulness in clinical practice.

Citing Articles

Limited Changes in Red Blood Cell Parameters After Probiotic Supplementation in Depressive Individuals: Insights from a Secondary Analysis of the PRO-DEMET Randomized Controlled Trial.

Gajewska A, Wysokinski A, Strzelecki D, Gawlik-Kotelnicka O J Clin Med. 2025; 14(1.

PMID: 39797347 PMC: 11721667. DOI: 10.3390/jcm14010265.

References

Mancia G, Bombelli M, Facchetti R, Madotto F, Quarti-Trevano F, Polo Friz H . Long-term risk of sustained hypertension in white-coat or masked hypertension. Hypertension. 2009; 54(2):226-32. DOI: 10.1161/HYPERTENSIONAHA.109.129882. View

Ravenell J, Shimbo D, Booth 3rd J, Sarpong D, Agyemang C, Beatty Moody D . Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study. Circulation. 2017; 135(25):2470-2480. PMC: 5711518. DOI: 10.1161/CIRCULATIONAHA.116.027051. View

Siddiqui M, Judd E, Oparil S, Calhoun D . White-Coat Effect Is Uncommon in Patients With Refractory Hypertension. Hypertension. 2017; 70(3):645-651. PMC: 5552439. DOI: 10.1161/HYPERTENSIONAHA.117.09464. View

Pioli M, Ritter A, Faria A, Modolo R . White coat syndrome and its variations: differences and clinical impact. Integr Blood Press Control. 2018; 11:73-79. PMC: 6233698. DOI: 10.2147/IBPC.S152761. View

Shi X, Zhang K, Wang P, Kan Q, Yang J, Wang L . Association of masked uncontrolled hypertension and cardiovascular diseases in treated hypertensive patients. Arch Med Sci. 2020; 16(3):538-544. PMC: 7212231. DOI: 10.5114/aoms.2019.89218. View

Bohm M, Schumacher H, Teo K, Lonn E, Mahfoud F, Mann J . Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials. Lancet. 2017; 389(10085):2226-2237. DOI: 10.1016/S0140-6736(17)30754-7. View

Banegas J, Ruilope L, De La Sierra A, de la Cruz J, Gorostidi M, Segura J . High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J. 2014; 35(46):3304-12. DOI: 10.1093/eurheartj/ehu016. View

Hoegholm A, Bang L, Kristensen K, Nielsen J, Holm J . Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normotension. Hypertension. 1994; 24(1):101-5. DOI: 10.1161/01.hyp.24.1.101. View

Hansen T, Kikuya M, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T . Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens. 2007; 25(8):1554-64. DOI: 10.1097/HJH.0b013e3281c49da5. View

10.

. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. Lancet. 2016; 389(10064):37-55. PMC: 5220163. DOI: 10.1016/S0140-6736(16)31919-5. View

11.

Naser N, Dzubur A, Durak A, Kulic M, Naser N . Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH). Med Arch. 2016; 70(4):274-279. PMC: 5034977. DOI: 10.5455/medarh.2016.70.274-279. View

12.

Head G, Mihailidou A, Duggan K, Beilin L, Berry N, Brown M . Definition of ambulatory blood pressure targets for diagnosis and treatment of hypertension in relation to clinic blood pressure: prospective cohort study. BMJ. 2010; 340:c1104. PMC: 2854890. DOI: 10.1136/bmj.c1104. View

13.

Wright Jr J, Williamson J, Whelton P, Snyder J, Sink K, Rocco M . A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med. 2015; 373(22):2103-16. PMC: 4689591. DOI: 10.1056/NEJMoa1511939. View

14.

Pickering T, White W . ASH Position Paper: Home and ambulatory blood pressure monitoring. When and how to use self (home) and ambulatory blood pressure monitoring. J Clin Hypertens (Greenwich). 2009; 10(11):850-5. PMC: 8672981. DOI: 10.1111/j.1751-7176.2008.00043.x. View

15.

Siu A . Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2015; 163(10):778-86. DOI: 10.7326/M15-2223. View

16.

Kikuya M, Hansen T, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T . Diagnostic thresholds for ambulatory blood pressure monitoring based on 10-year cardiovascular risk. Blood Press Monit. 2008; 12(6):393-5. DOI: 10.1097/MBP.0b013e3282f2b53d. View

17.

Thomopoulos C, Parati G, Zanchetti A . Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials. J Hypertens. 2016; 34(4):613-22. DOI: 10.1097/HJH.0000000000000881. View

18.

Parati G, Stergiou G, OBrien E, Asmar R, Beilin L, Bilo G . European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens. 2014; 32(7):1359-66. DOI: 10.1097/HJH.0000000000000221. View

19.

Ghazi L, Cohen L, Muntner P, Shimbo D, Drawz P . Effects of Intensive Versus Standard Office-Based Hypertension Treatment Strategy on White-Coat Effect and Masked Uncontrolled Hypertension: From the SPRINT ABPM Ancillary Study. Hypertension. 2020; 76(4):1090-1096. PMC: 7484232. DOI: 10.1161/HYPERTENSIONAHA.120.15300. View

20.

Kario K, Shimada K, Schwartz J, Matsuo T, Hoshide S, Pickering T . Silent and clinically overt stroke in older Japanese subjects with white-coat and sustained hypertension. J Am Coll Cardiol. 2001; 38(1):238-45. DOI: 10.1016/s0735-1097(01)01325-0. View